Technology, human ingenuity and deep pools of financial capital are aligned in an important mission: bringing artificial intelligence (AI) to global healthcare. If investor enthusiasm is any gauge, the mission is advancing quickly. No fewer than 300 healthcare AI startups have closed funding deals in the last five years—nearly 45% of them first equity rounds by startups just entering the space.
This new Syneos Health patient survey of about 800 European and American patients and 200 caregivers, hopes to address this deficit and shift the conversation from what AI means for healthcare providers, product companies and investors to what AI should do for patients. Responding to wide-ranging questions, large majorities of patients said they have certain fears about AI’s future prominence, and that they want physicians to oversee the development and use of healthcare AI applications.
To download the analysis from In Vivo Pharma Intelligence simply log in or register for a KNect365 account, which will give you access to all our exclusive premium content.
Log in or Create an Informa Connect Account to Access this content
Creating an account also means you'll get special access to article updates and exclusive industry content.